ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KAREN HENLEY MD

Psychiatry

2,988

$137K

165
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $110

EILEEN WONG M.D.

Psychiatry

2,987

$397K

101
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$133
Average prescription price

Avg: $110

ANDREW KWAIT MD

Psychiatry

2,983

$515K

185
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 20%

$173
Average prescription price

Avg: $110

VICTORIA SHEA M.D.

Psychiatry

2,983

$382K

154
0 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$128
Average prescription price

Avg: $110

GYORGY BODROG M.D.

Psychiatry

2,972

$355K

216
0 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$119
Average prescription price

Avg: $110

THOMAS MCLAUGHLIN MD

Psychiatry

2,961

$425K

85
0 are 65+

35%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$143
Average prescription price

Avg: $110

ASTRID DESROSIERS MD MPH

Psychiatry

2,842

$427K

137
38 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 20%

$150
Average prescription price

Avg: $110

JUAN AVILA M.D.

Psychiatry

2,799

$187K

211
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 20%

$67
Average prescription price

Avg: $110

KALYANI SUBRAMANYAM M.D.

Psychiatry

2,796

$278K

160
13 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$99
Average prescription price

Avg: $110

JUAN ALONZO M.D.

Psychiatry

2,775

$291K

157
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $110

ROGER BOSHES M.D.

Psychiatry

2,757

$434K

145
0 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 20%

$157
Average prescription price

Avg: $110

MICHAEL PERLMAN MD

Psychiatry

2,675

$294K

128
46 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

CHRISTOPHER HARMON M.D.

Psychiatry

2,627

$270K

98
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

LALITH TISSERA M.D.

Psychiatry

2,576

$185K

199
72 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$72
Average prescription price

Avg: $110

JENNIFER MICHAELS M.D.

Psychiatry

2,566

$310K

155
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 20%

$121
Average prescription price

Avg: $110

ERWIN ILANO MD

Psychiatry

2,560

$252K

142
13 are 65+

29%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 20%

$99
Average prescription price

Avg: $110

MARK THALL M.D.

Psychiatry

2,547

$273K

193
62 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$107
Average prescription price

Avg: $110

KENNETH LAKRITZ MD

Psychiatry

2,535

$260K

228
131 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

SUSAN DONALDSON MD

Psychiatry

2,535

$280K

131
56 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

EDGARDO BIANCHI M.D.

Psychiatry

2,533

$273K

174
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$108
Average prescription price

Avg: $110

DAVID MCMAHON M.D.

Psychiatry

2,531

$248K

251
215 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 20%

$98
Average prescription price

Avg: $110

INNA KRUK M.D.

Psychiatry

2,510

$198K

164
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 20%

$79
Average prescription price

Avg: $110

HOWARD ABRAMS MD

Psychiatry

2,468

$265K

246
150 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$107
Average prescription price

Avg: $110

ROBERT SIGADEL MD

Psychiatry

2,436

$257K

138
0 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $110

SABRINA POPP M.D.

Psychiatry

2,433

$267K

98
29 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank